Please use this identifier to cite or link to this item:
https://doi.org/10.1186/1471-2334-14-289
| Title: | A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: The ASSURE study | Authors: | Stryjewski M.E. Lentnek A. O'Riordan W. Pullman J. Tambyah P.A. Miró J.M. Fowler Jr. V.G. Barriere S.L. Kitt M.M. Corey G.R. |
Issue Date: | 2014 | Publisher: | BioMed Central Ltd. | Citation: | Stryjewski M.E., Lentnek A., O'Riordan W., Pullman J., Tambyah P.A., Miró J.M., Fowler Jr. V.G., Barriere S.L., Kitt M.M., Corey G.R. (2014). A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: The ASSURE study. BMC Infectious Diseases 14 (1) : 289. ScholarBank@NUS Repository. https://doi.org/10.1186/1471-2334-14-289 | Source Title: | BMC Infectious Diseases | URI: | http://scholarbank.nus.edu.sg/handle/10635/143213 | ISSN: | 14712334 | DOI: | 10.1186/1471-2334-14-289 |
| Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| 1471-2334-14-289.pdf | 584.97 kB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.